Abrdn Life Sciences Investors (NYSE:HQL) Shares Purchased by Allspring Global Investments Holdings LLC

Allspring Global Investments Holdings LLC lifted its stake in Abrdn Life Sciences Investors (NYSE:HQL) by 30.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 454,154 shares of the company’s stock after acquiring an additional 106,539 shares during the period. Allspring Global Investments Holdings LLC’s holdings in Abrdn Life Sciences Investors were worth $6,113,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also made changes to their positions in HQL. Comerica Bank acquired a new stake in Abrdn Life Sciences Investors in the third quarter worth approximately $42,000. Blue Bell Private Wealth Management LLC raised its stake in shares of Abrdn Life Sciences Investors by 60.4% in the 4th quarter. Blue Bell Private Wealth Management LLC now owns 10,125 shares of the company’s stock worth $136,000 after buying an additional 3,811 shares in the last quarter. International Assets Investment Management LLC lifted its holdings in shares of Abrdn Life Sciences Investors by 3,424.5% in the fourth quarter. International Assets Investment Management LLC now owns 11,067 shares of the company’s stock valued at $149,000 after buying an additional 10,753 shares during the period. Money Concepts Capital Corp bought a new position in Abrdn Life Sciences Investors during the fourth quarter valued at about $160,000. Finally, B. Riley Wealth Advisors Inc. acquired a new position in Abrdn Life Sciences Investors during the fourth quarter worth about $167,000. 32.21% of the stock is currently owned by institutional investors.

Abrdn Life Sciences Investors Trading Up 0.0 %

Shares of Abrdn Life Sciences Investors stock opened at $12.80 on Friday. Abrdn Life Sciences Investors has a 52 week low of $11.34 and a 52 week high of $14.37. The company’s 50-day moving average price is $13.59 and its two-hundred day moving average price is $13.08.

Abrdn Life Sciences Investors Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, March 28th. Investors of record on Thursday, February 22nd were issued a $0.39 dividend. This is an increase from Abrdn Life Sciences Investors’s previous quarterly dividend of $0.30. This represents a $1.56 dividend on an annualized basis and a dividend yield of 12.19%. The ex-dividend date was Wednesday, February 21st.

Abrdn Life Sciences Investors Profile

Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries.